U.S. Infectious Disease Molecular Diagnostics Market Size & Outlook
The infectious disease molecular diagnostics market in the United States is expected to reach a projected revenue of US$ 7,175.8 million by 2030. A compound annual growth rate of 3.6% is expected of the United States infectious disease molecular diagnostics market from 2025 to 2030.
- Clinical Diagnostics
- In Vitro Diagnostics
- Infectious Disease Molecular Diagnostics Market Outlook
- In Vitro Diagnostics